MedPath

Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction

Completed
Conditions
Chronic Kidney Disease 5D
Heart Failure NYHA Class II
Heart Failure
Heart Failure NYHA Class I
Interventions
Procedure: Hemodialysis session
Registration Number
NCT06394986
Lead Sponsor
Moscow Regional Research and Clinical Institute (MONIKI)
Brief Summary

This is a single-arm cohort study aimed to evaluate change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session after a "long" interdialysis interval.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • signed informed consent,
  • > 18 years
  • maintenance ("chronic") hemodialysis,
  • native arteriovenous fistula,
  • arteriovenous fistula volume blood flow ≥1 l/min,
  • arteriovenous fistula volume blood flow / cardiac output ratio < 0.3,
  • interdialysis weight gain <5% of "dry" body weight,
  • sufficient hemodialysis dose (eKt/V > 1.2),
  • chronic heart failure (NYHA I-II classes only),
  • preserved left ventricular ejection fraction (≥50%),
  • absence of arrhythmias (except first-degree atrioventricular block block),
  • absence of heart valve disease (except mitral regurgitation grade I-II),
  • absence of intradialysis hypo/hypertension
  • "long" interdialysis interval (3 days).
Exclusion Criteria
  • hypo/hypertension during or after hemodialysis,
  • arrhythmias (except first-degree atrioventricular block) after hemodialysis.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Study groupHemodialysis session-
Primary Outcome Measures
NameTimeMethod
Change in cardio-fistular recirculationOne hour before and two hours after the hemodialysis session.

Change in arteriovenous fistula volume blood flow / cardiac output ratio

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Moscow Regional Research and Clinical Institute (MONIKI)

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath